Pilot Chemical Adds EPA Emerging Viral Pathogen Claim to 8 Products

Pilot Chemical Corp. announced that, through its subsidiary Mason Chemical Company, it has received EPA acceptance to add an emerging viral pathogen claim to the labels of eight products from the company’s EPA-registered quaternary ammonium compound and active ingredient line, under its Maquat and Maguard brands. 

Emerging viral pathogens are defined by the National Institute of Allergy and Infectious Diseases as pathogens “that have newly appeared in a population or have existed but are rapidly increasing in incidence or geographic range.” 

In the case of SARS-CoV-2, the product must have the emerging viral pathogen language on the label and be effective against a harder-to-kill virus than SARS-CoV-2. 

“Meeting the EPA’s criteria for effectiveness against emerging viral pathogens enables our customers to make off- label claims that their products can fight the virus that causes COVID-19 and future threats that may emerge,” said Richard Rehg, VP of Commercial, Pilot Chemical Company. “Our team has been working hard to bring this to fruition and help our customers offer effective formulated products to meet rapidly changing market needs.”